NervGen Pharma Reports Q2 2024 Financial Results and Operational Updates

Go back to NervGen Pharma Reports Q2 2024 Financial Results and Operational Updates
(AMEX: NGENF) Delayed: 5.84 --0 (-0%)
Previous Close $5.84    52 Week High
Open $5.84    52 Week Low
Day High $5.84    P/E N/A 
Day Low $5.84    EPS
Volume 904